Loading...
StocksRunner logo
 
  Overview  
 
  Earnings  
 
  Calendar  
 
  Headlines  
 
  Posts  
 
 
Boston Scientific
54.82
-0.11%
 

BSX Stock Analysis

 
 
BSX

Boston Scientific

Last Price
Change
54.82
 
-0.11%
 
 
 
Total Score
 
score
4.08
 
StocksRunner
Strong Sell
Hold
Strong Buy
 
 

Summary

Boston Scientific (BSX) Receives Strong Buy Recommendation with an Overall Score of 4.08 based on 37 events in the last 90 days from financial news and social media. Last updated Dec 6, 2023 21:44
 
 

Chart

 
 

50.96

53.42

53.16

47.2

 
 
1m
3m
6m
1y
 
 

Strengths

Rewards

 Upgraded on attractively valued

Rewards

 Earnings are forecast to grow

Rewards

 Analysts raised price target

 

Risk Analysis

Risk Analysis

 Insider selling during the past 3 months

 
 

Risk Level

 
Risk Level
LOW
HIGH
 

Boston Scientific (BSX) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Above analyst estimates

StocksRunner

 Sales increase

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 

StocksRunner

 Price value has negative momentum

 

Activity

×
 

Activity

3.00
 

StocksRunner

 Insider selling during the past 3 months

 

Future

×
 

Future

4.07
 

StocksRunner

 Earnings are forecast to grow

StocksRunner

 Analysts raised price target

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
73%
100%
0%
86%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
73%
22%
Positive
Negative
27 out of 37
events present
8 out of 37
events present
 
 
Events Calendar
Click for more information
 
November
S
M
T
W
T
F
S
December
S
M
T
W
T
F
S
 
 
Earnings
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
13,757
12,682
11,888
+7.57%
 
 
Cost of Revenue
4,256
4,003
3,760
+6.39%
 
 
Gross Profit
9,501
8,679
8,128
+8.12%
 
 
Operating Expense
7,175
6,646
6,304
+6.68%
 
 
Operating Income
2,326
2,033
1,824
+12.93%
 
 
Net Interest Income
-254
-470
-341
-13.69%
 
 
Interest Expense
264
470
341
-12.01%
 
 
Interest Income
-
10
4
-
 
 
Other Income
-197
-424
-408
-30.51%
 
 
EPS
0.83
0.45
0.69
+9.68%
 
 
Next Earnings Date: Jan 30, 2024
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Buy Rating
2 Month Ago
49.54
-0.46%
 
Strong Earnings
2 Month Ago
49.78
-0.42%
 
Investors Selling
2 Month Ago
48.64
-4.46%
 
Insider Selling
2 Month Ago
50.93
-5.36%
 
Top Headlines






















 
 
 
joker
 
 
 
StocksRunner

Explore our BSX stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our BSX Daily Alerts

Unlock the knowledge that 250,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
 
 

BSX Stock Analysis and Insights

 
 
 
 

Economic Data

 
 
 
 
Today
December 6
 
 
USA Balance of Trade
 

Actual

$-64.3B

Previous

$-61.2B

 
Tomorrow
December 7
 
 
USA Initial Jobless Claims
 

Previous

218K

Forecast

225.0K

 
Friday
December 8
 
 
USA Non Farm Payrolls
 

Previous

150K

Forecast

160K

USA Unemployment Rate
 

Previous

3.90%

Forecast

3.90%

 
 
 
 

Stock Analysis and Insights

 
 
 
 
BSX Boston Scientific
Last Price
Change
54.82
 
-0.11%
 
 
 
  Overview  
 
  Earnings  
 
  Calendar  
 
  Headlines  
 
  Posts  
 

 
joker
 
 
 
Total Score
 
score
4.08
 
StocksRunner
Strong Sell
Hold
Strong Buy
 
 

Summary

Boston Scientific (BSX) Receives Strong Buy Recommendation with an Overall Score of 4.08 based on 37 events in the last 90 days from financial news and social media. Last updated Dec 6, 2023 21:44
 
 

Chart

 
 

50.96

53.42

53.16

47.2

 
 
1m
3m
6m
1y
 
 

Strengths

Rewards

 Upgraded on attractively valued

Rewards

 Earnings are forecast to grow

Rewards

 Analysts raised price target

 

Risk Analysis

Risk Analysis

 Insider selling during the past 3 months

 
 

Risk Level

 
Risk Level
LOW
HIGH
 

Boston Scientific (BSX) has Low Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

4.00
 

StocksRunner

 Above analyst estimates

StocksRunner

 Sales increase

 
 

Rating

×
 

Rating

5.00
 

StocksRunner

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

3.00
 

StocksRunner

 Price value has negative momentum

 

Activity

×
 

Activity

3.00
 

StocksRunner

 Insider selling during the past 3 months

 

Future

×
 

Future

4.07
 

StocksRunner

 Earnings are forecast to grow

StocksRunner

 Analysts raised price target

 
 

Analysts Opinion

Analysts opinion is positive and also has improved from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
73%
100%
0%
86%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
73%
22%
Positive
Negative
27 out of 37
events present
8 out of 37
events present
 

 

Events Calendar

Hover for information

 
November
 
S
M
T
W
T
F
S
 
December
 
S
M
T
W
T
F
S
 
 
 
Earnings
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
13,757
12,682
11,888
+7.57%
 
 
Cost of Revenue
4,256
4,003
3,760
+6.39%
 
 
Gross Profit
9,501
8,679
8,128
+8.12%
 
 
Operating Expense
7,175
6,646
6,304
+6.68%
 
 
Operating Income
2,326
2,033
1,824
+12.93%
 
 
Net Interest Income
-254
-470
-341
-13.69%
 
 
Interest Expense
264
470
341
-12.01%
 
 
Interest Income
-
10
4
-
 
 
Other Income
-197
-424
-408
-30.51%
 
 
EPS
0.83
0.45
0.69
+9.68%
 
 
Next Earnings Date: Jan 30, 2024
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Buy Rating
2 Month Ago
49.54
-0.46%
 
Strong Earnings
2 Month Ago
49.78
-0.42%
 
Investors Selling
2 Month Ago
48.64
-4.46%
 
Insider Selling
2 Month Ago
50.93
-5.36%
 
Top Headlines






















 
 
 
 
 

Market Overview

 
 
 

Based on 4,683 events Last updated Dec 6, 2023 21:44

 
StocksRunner
sentiment
45%
51%
Negative
Positive
 
Indicator
Health
  %

Market
 
    51%
 
Potential
 
    82%
 
Momentum
 
    39%
 
Earnings
 
    67%
 
Rating
 
    70%
 
 
 
 
 
 
 
StocksRunner

Discover BSX stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of BSX. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our BSX Daily Alerts

Unlock the knowledge that 250,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

BSX stock trends

BSX stock performance

BSX Stock analysis

BSX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker